Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: ValuEngine, Inc.
$25.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

AstraZeneca PLC, Teva Pharmaceutical Industries Ltd Seek To Buy Amarin Corporation PLC-Reuters


Thursday, 15 Nov 2012 05:20am EST 

Reuters reported that Teva Pharmaceutical Industries Ltd is a leading candidate to buy Amarin Corporation PLC the Calcalist financial daily reported. Calcalist said British drugmaker AstraZeneca PLC was also looking to buy Amarin, which has a market value on Nasdaq of $1.6 billion. A spokeswoman for Israel-based Teva said the company did not comment on rumours. 

Company Quote

74.67
-0.05 -0.07%
22 Sep 2014